YBa/sub 2/Cu/sub 3/O/sub 7-x/-Y/sub 2/Ba/sub 4/Cu/sub 8/O/sub x/
Reactivity of Au/La<sub>1 x</sub>Sr<sub>x</sub>Cr<sub>1 y</sub>Ni<sub>y</sub>O<sub>3 δ</sub> toward Oxidative Coupling of Methane for C<sub>2</sub> and C<sub>3</sub> Hydrocarbons Production
... Lacking of fossil fuels and the current global warming crisis drive the researchers to find new energy resources, which are of high efficiency and environmental friendly. Solid oxide fuel cell (SOFC) is known as an ...
12
Biocompatibility of magnetic Fe<sub>3</sub>O<sub>4</sub> nanoparticles and their cytotoxic effect on MCF-7 cells
... Fe 3 O 4 nanoparticles were approximately spherical, with diameters of about ...the x-ray diffraction data with Joint Corporation of Powder Dif- fraction Standards (JCPDS) X-ray powder ...
10
Effect of Cobalt Precursors on Properties of Co/CoAl<sub>2</sub>O<sub>4</sub> Catalysts Synthesized by Solvothermal Method
... Many transition metals of Group VIII can be used as catalysts for FTS, such as iron (Fe), cobalt (Co), nickel (Ni), and ruthenium (Ru) [2-4]. However, supported cobalt catalysts are preferred for FTS ...
10
Biosafety evaluation of Janus Fe<sub>3</sub>O<sub>4</sub>-TiO<sub>2</sub> nanoparticles in Sprague Dawley rats after intravenous injection
... caspase 3, Bcl2, Bax, p50, p53, Nrf2, Akt, and GAPDH were obtained from Cell Signaling Technology (Danvers, MA, ...Fe 3 O 4 -TiO 2 NPs and TiO 2 NPs were obtained from our ...
15
Biological responses to core–shell-structured Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>-NH<sub>2</sub> nanoparticles in rats by a nuclear magnetic resonance-based metabonomic strategy
... a 2-week acclimatization for Fe@Si NP intravenous adminis- tration: control group, low-dose 10 nm Fe@Si NP-exposure group (10L), low-dose 20 nm Fe@Si NP-exposure group (20L), high-dose 20 nm Fe@Si NP-exposure ...
16
Toxicity evaluation of Gd<sub>2</sub>O<sub>3</sub>@SiO<sub>2</sub> nanoparticles prepared by laser ablation in liquid as MRI contrast agents in vivo
... Notes: (A) cell viability of l929 cells incubated with different concentrations (10 µM, 1 µM, and 100 nM) of the gd-NPs for 24 and 48 hours. (B) apoptosis rates of Raw264.7 cells were measured by flow cytometry at 48 ...
11
In vitro toxicity of Fe<sub>m</sub>O<sub>n</sub>, Fe<sub>m</sub>O<sub>n</sub>-SiO<sub>2</sub> composite, and SiO<sub>2</sub>-Fe<sub>m</sub>O<sub>n</sub> core-shell magnetic nanoparticles
... NH 4 OH and 1% ammonium acetate was added to FeSO 4 and Fe 2 (SO 4 ) 3 (molar ratio 2:1) in 700 mL of distilled water under intensive stirring at a rate of 4 mL/min until ...
11
Effect of interaction of magnetic nanoparticles of Fe<sub>3</sub>O<sub>4</sub> and artesunate on apoptosis of K562 cells
... purchased: 3-(4, 5- dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT) (Ameresco, Solon, OH); Z-VAD-FMK (Beyotime Biotechnology); RPMI 1640 medium and fetal calf serum (GIBCO, USA); ...
8
Gd<sub>2</sub>O<sub>3</sub> nanoparticles in hematopoietic cells for MRI contrast enhancement
... acetate in 50% ethanol over night. Continuing dehydration steps was 70%, 85%, and 95% ethanol for 5 minutes each and 100% ethanol for 10 minutes. Embedding was then per- formed in 100% ethanol and Epon 812 (Shell ...
8
In vitro and in vivo targeting imaging of pancreatic cancer using a Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanoprobe modified with anti-mesothelin antibody
... The T2 signal values of experimental group xenograft were decreased by 342.533 ± 42.6 after injection of the target probe, and the control group was decreased by − 61.233 ± 33.9 after injection of saline solution, while ...
13
Biocompatibility of Fe<sub>3</sub>O<sub>4</sub>/DNR magnetic nanoparticles in the treatment of hematologic malignancies
... Fe 3 O 4 ...Fe 3 O 4 -MNPs/DNR groups and negative controls (P ...Fe 3 O 4 -MNPs/DNR was ...Fe 3 O 4 -MNPs/ DNR groups were ...Fe ...
6
Synthesis of composite magnetic nanoparticles Fe<sub>3</sub>O<sub>4</sub> with alendronate for osteoporosis treatment
... H 8 O 6 ; Sigma-Aldrich ...(NaHCO 3 ; Sigma-Aldrich ...[KH 2 PO 4 ; Sigma-Aldrich ...[Na 2 HPO 4 ; Sigma-Aldrich ...and ...
12
R<sub>2(GFR)</sub>CHADS<sub>2</sub> and R<sub>2(GFR)</sub>CHA<sub>2</sub>DS<sub>2</sub>VASc schemes improved the performance of CHADS<sub>2</sub> and CHA<sub>2</sub>DS<sub>2</sub>VASc scores in death risk stratification of Chinese older patients with atrial fibrillation
... R 2 CHADS 2 and R 2 CHA 2 DS 2 VASc schemes by combining CrCl and GFR with CHADS 2 and CHA 2 DS 2 VASc ...CHADS 2 and CHA 2 DS 2 VASc scores ...
6
Polyetherimide-grafted Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanoparticles as theranostic agents for simultaneous VEGF siRNA delivery and magnetic resonance cell imaging
... from healthy Sprague Dawley rats was collected in heparin- coated tubes. The red blood cells (RBCs) were obtained by centrifugation at 1,500 rpm for 5 minutes, and the upper plasma was removed. The RBCs were then washed ...
13
Pharmacokinetic parameters and tissue distribution of magnetic Fe<sub>3</sub>O<sub>4</sub> nanoparticles in mice
... Fe 3 O 4 MNPs in the various organs and tissues is shown in Figures 3 and ...Fe 3 O 4 MNPs at all time points between the experimental and control groups, there were ...
6
Biocompatibility of Fe<sub>3</sub>O<sub>4</sub>@Au composite magnetic nanoparticles in vitro and in vivo
... NH 2 OH 3 HCl and HAuCl 4 ) were performed during the reaction, and the stirring continued for at least 30 minutes after each ...Fe 3 O 4 @Au composite ...
15
Fe<sub>3</sub>O<sub>4</sub>-based PLGA nanoparticles as MR contrast agents for the detection of thrombosis
... Fe 3 O 4 -PLGA NP group and the Fe 3 O 4 -PLGA- cRGD NP ...FeCl 3 injury to the abdominal aorta and at 0 min, 10 min, 20 min, 30 min, 1 h, 2 h, and 3 h after ...
14
The effect of magnetic nanoparticles of Fe<sub>3</sub>O<sub>4</sub> on immune function in normal ICR mice
... CO 2 atmosphere, following which 10 µ L MTT ...least 4 hours, the formazan crystals were dissolved in 150 µ L dimethyl sulfoxide (Sigma Aldrich) and the reduc- tion of MTT was quantified by absorbance at a ...
7
Magnetic nanoparticles of Fe<sub>3</sub>O<sub>4</sub> enhance docetaxel-induced prostate cancer cell death
... strategy is to treat tumor cells with antioxidants, such as through the dietary administration of red wine and green tea polyphenols to prevent cancer. The other strategy is to provide pro-oxidant therapy, which consists ...
10
Effect of Fe<sub>3</sub>O<sub>4</sub>-magnetic nanoparticles on acute exercise enhanced KCNQ<sub>1</sub> expression in mouse cardiac muscle
... 12PE. These results indicated that the administration of MNPs-Fe 3 O 4 did not cause any appar- ent effects on the expression profile of KCNQ 1 in rested or exercised mice cardiac muscle. Our studies ...
8